Skip to main content

Lab-to-Table Conversations

Sign up here to receive an invitation to our monthly conversations!

Jun 17, 2021, 12:00 pm CT
“Origins of Life: A conversation between a cell biologist, theologian, astronomer, and philosopher”   View this conversation 

May 26, 2021
“How the Brain Remembers” — a Conversation with New York Times bestselling author and neuroscientist Lisa Genova and Vanderbilt Brain Institute Barlow Family Director Lisa Monteggia. This event was presented in partnership with Nashville-based Parnassus Books.  View this conversation

April 27, 2021
“Vanderbilt Center for Addiction Research — a Conversation with Langhorne Slim”
Featured guest, musician Langhorne Slim, discusses addiction recovery with Vanderbilt Center for Addiction Research researchers Danny Winder and Erin Calipari.  View this conversation!

April 21, 2021
“Addiction, Sobriety and Art in the Time of COVID-19”
Featured guest, Will Welch, global editorial director of GQ magazine will join Winder and Calipari for the discussion. Welch has had personal experience with addiction and sobriety and has made discussing these issues through articles like “Creating While Clean” a focus of GQ in recent years. View this conversation!

March 30, 2021
“On the Cutting-Edge: Research Toward a Cure for Colorectal Cancer”
Featuring David Cortez (moderator) and panelists Jordan Berlin, Robert Coffey, Ethan Lee, and Alissa Weaver.  View this conversation!   Vanderbilt-Ingram Cancer Center colorectal cancer resources

February 15, 2021
“Inclusion and Equity in Biomedical Research”
Featuring André Churchwell (moderator) and panelists Breann Brown, Renã Robinson, and Steven Townsend.

View article   View this conversation!

October 6, 2020
“Depression and the Brain: A Paradigm Shift in Psychiatry and Neuroscience”
October is depression awareness month. An estimated 17.3 million adults in the United States had at least one major depressive episode in 2017. This number represented 7.1% of all U.S. adults. To align with awareness on this illness, Dr. Lisa Monteggia covers the ground-breaking research occurring in basic science focused on depression, which she counts as one of our strongest research areas. Dr. Monteggia discussed the recent breakthroughs and future directions our research will take. View this talk!

July 3, 2020
“A Promising Start to Ending Coronaviruses”
Featuring Stephen W. Fesik, Orrin H. Ingram II Chair in Cancer Research. Steve Fesik, PhD, discusses his research on protease inhibitors for coronaviruses.  View this talk!

August 4, 2020
“Meeting the Challenge: Neuroscience Drug Discovery with the Warren Center”
The Warren Center for Neuroscience Drug Discovery (WCNDD) extends traditional academic pursuits in basic science to take the most exciting advances in our understanding of human disease and drug targets to a point where these breakthroughs can directly impact patient care. This is especially true in discovery of new treatment strategies for the most serious of brain disorders, such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, autism, and others. By incorporating the highest level of drug discovery into academic research, the WCNDD takes scientific breakthroughs beyond the lab and toward the development of patentable and marketable drugs suited for clinical studies. Jeff Conn and Craig Lindsley give an overview of WCNDD, their neuroscience research and describe the impact of the transformative gift from The William K. Warren Foundation. View this talk!